» Articles » PMID: 1087592

Plasma Factors in Delayed-type Hypersensitivity. Augmentation of Lymphocyte Responses in Borderline Leprosy Reactions

Overview
Date 1976 Dec 1
PMID 1087592
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The phytohaemagglutinin-induced responses of lymphocytes were found to be inhibited by plasma from patients with leprosy when compared with their responses in pooled serum from healthy donors. When patients developed reversal reactions, the initial inhibitory effect of their plasma was replaced by an augmentary effect on the responses to phytohaemagglutinin. The period of augmentation coincided with that of the reversal reaction in patients with borderline tuberculoid leprosy, but was delayed in patients with borderline lepromatous leprosy. The plasma from each leprosy patient was also observed to have the same effect on lymphocytes from unrelated individuals, showing that the inhibition and augmentation were due to factors in the plasma and not to a change in lymphocyte receptors. It is possible that the normal stable state of leprosy results from the presence of factors in plasma which act as a control mechanism, and that delayed hypersensitivity reactions may be caused by a breakdown of this control.

Citing Articles

Effect of restricted dissolved oxygen on expression of Clostridium difficile toxin A subunit from E. coli.

Sharma A, Phue J, Khatipov E, Dalal N, Anderson E, Shiloach J Sci Rep. 2020; 10(1):3059.

PMID: 32080292 PMC: 7033237. DOI: 10.1038/s41598-020-59978-1.


Studies on T cell subsets and functions in leprosy.

Bach M, Chatenoud L, Wallach D, Phan Dinh Tuy F, COTTENOT F Clin Exp Immunol. 1981; 44(3):491-500.

PMID: 6459897 PMC: 1537313.


Successful plasma exchange in type 1 leprosy reversal reaction.

Lucht F, Rifle G, Portier H, Chalopin J, Bonhomme J Br Med J (Clin Res Ed). 1984; 289(6459):1647-8.

PMID: 6439359 PMC: 1443843. DOI: 10.1136/bmj.289.6459.1647.


Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.

Bjune G, Closs O, Barnetson R Clin Exp Immunol. 1983; 54(2):289-97.

PMID: 6228348 PMC: 1535902.


Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.

Bahr G, Rook G, Moreno E, Lydyard P, Modabber F, Stanford J Immunology. 1980; 41(4):865-73.

PMID: 6161879 PMC: 1458311.


References
1.
Fitzgerald M, Hosking C . Plasma inhibitors of lymphocyte response to phytohaemagglutinin in children with recurrent infections. Immunology. 1976; 30(1):33-42. PMC: 1444958. View

2.
Gatti R . Serum inhibitors of lymphocyte responses. Lancet. 1971; 1(7713):1351-2. DOI: 10.1016/s0140-6736(71)91906-4. View

3.
Suciu-Foca N, Buda J, McManus J, Thiem T, REEMTSMA K . Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer. Cancer Res. 1973; 33(10):2373-7. View

4.
Barnetson R, Bjune G, Pearson J, Kronvall G . Antigenic heterogeneity in patients with reactions in borderline leprosy. Br Med J. 1975; 4(5994):435-7. PMC: 1675388. DOI: 10.1136/bmj.4.5994.435. View

5.
Godal T, Myrvang B, Samuel D, ROSS W, Lofgren M . Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report. Acta Pathol Microbiol Scand Suppl. 1973; 236(0):45-53. View